Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-07-001070
Filing Date
2007-04-20
Accepted
2007-04-20 09:34:26
Documents
5
Period of Report
2007-05-17
Effectiveness Date
2007-04-20

Document Format Files

Seq Description Document Type Size
1 NOTICE OF PROXY STATEMENT avant_nps1.htm DEF 14A 331229
2 GRAPHIC avant_nps1x1x1.jpg GRAPHIC 12438
3 GRAPHIC avant_nps1x1x2.jpg GRAPHIC 7157
4 GRAPHIC avant_nps1x2x2.jpg GRAPHIC 6728
5 GRAPHIC proxycardx1x1.jpg GRAPHIC 7964
  Complete submission text file 0001206774-07-001070.txt   380595
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 07777444
SIC: 2835 In Vitro & In Vivo Diagnostic Substances